Charts Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Singapore S.E.
Equities
T14
CNE100000924
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.99 USD | -0.50% | 0.00% | -3.86% |
30/04 | Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3% | MT |
30/04 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Recommends Dividend | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Neutral | Neutral |
Resistance | 2.040 | 2.080 | 2.200 |
Spread/Res. | -2.45% | -4.33% | -9.55% |
Spread/Supp. | +2.05% | +18.45% | +17.75% |
Support | 1.950 | 1.680 | 1.690 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- 600329 Stock
- T14 Stock
- Charts Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited